Bristol-Myers Squibb Company (BMY)
NYSE
67.28
+0.27 (+0.40%)
Closed
Aug 24, 2026
Day's Range
66.4567.41
52 wk Range
42.5268.64
Financial Statements - BMY - Bristol-Myers Squibb Company
Revenue
48.19B▼ 0.2%
Net Income
7.05B▲ 179.0%Net Margin 14.6%
EBITDA
19.94B▲ 16.2%
Free Cash Flow
12.84B▼ 7.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 48.19B | 48.30B | 45B | 46.15B | 46.38B | 42.51B |
| Cost of Goods | 13.93B | 13.96B | 10.69B | 10.13B | 9.94B | 11.77B |
| Gross Profit | 34.25B | 34.33B | 34.31B | 36.02B | 36.44B | 30.74B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 13.72B | 5.88B | 8.19B | 9.10B | 8.53B | 2.17B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -2.50B | -12.31B | 1.41B | -159M | 895M | -7.62B |
| Pre Tax Income | 9.32B | -8.37B | 8.44B | 7.71B | 8.09B | -6.87B |
| Income Tax | 2.27B | 554M | 400M | 1.36B | 1.08B | 2.12B |
| Net Income | 7.05B | -8.93B | 8.04B | 6.34B | 7.01B | -8.99B |
| EPS Basic | 3.47 | -4.41 | 3.88 | 2.97 | 3.15 | -3.99 |
| EPS Diluted | 3.46 | -4.41 | 3.86 | 2.95 | 3.12 | -3.99 |
| Basic Shares Outstanding | 2.03B | 2.02B | 2.06B | 2.13B | 2.22B | 2.25B |
| Diluted Shares Outstanding | 2.03B | 2.02B | 2.06B | 2.13B | 2.22B | 2.25B |
| Ebit | 11.21B | -6.43B | 9.60B | 8.94B | 9.43B | -5.45B |
| Ebitda | 19.94B | 17.16B | 19.33B | 20.57B | 20.37B | 14.28B |
| Net Income Continuous Operations | 7.05B | -8.93B | 8.04B | 6.34B | 7.01B | -8.99B |
| Minority Interests | -2M | -15M | -15M | -18M | -20M | -20M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
